Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-05-01 00:00:00 ET · period of report 2024-04-29 · accession 0001668397-24-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-01 | 2024-04-29+ | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $400.65 | -16.9K | 791.5K | -2% | -$6.78M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | S | D | 1,828 | $400.31 | 789,713 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $400.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-04-29 | S | D | 15,102 | $400.69 | 791,541 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $402.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |